Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tannith M. Noye"'
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 12, p 4122 (2018)
S100A10, which is also known as p11, is located in the plasma membrane and forms a heterotetramer with annexin A2. The heterotetramer, comprising of two subunits of annexin A2 and S100A10, activates the plasminogen activation pathway, which is involv
Externí odkaz:
https://doaj.org/article/5dae557babc04c248471cf5b1d909165
Autor:
Mitchell Acland, Noor A. Lokman, Clifford Young, Dovile Anderson, Mark Condina, Chris Desire, Tannith M. Noye, Wanqi Wang, Carmela Ricciardelli, Darren J. Creek, Martin K. Oehler, Peter Hoffmann, Manuela Klingler-Hoffmann
Publikováno v:
Cancers; Volume 14; Issue 11; Pages: 2763
Chemoresistance remains the major barrier to effective ovarian cancer treatment. The molecular features and associated biological functions of this phenotype remain poorly understood. We developed carboplatin-resistant cell line models using OVCAR5 a
Autor:
Carmela Ricciardelli, Noor A. Lokman, Wanqi Wang, Anne M. Macpherson, Tannith M. Noye, Martin K. Oehler
Publikováno v:
Cancer Drug Resistance.
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 12, p 4122 (2018)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Refereed/Peer-reviewed S100A10, which is also known as p11, is located in the plasma membrane and forms a heterotetramer with annexin A2. The heterotetramer, comprising of two subunits of annexin A2 and S100A10, activates the plasminogen activation p
S100A10, which is also known as p11 is located in the plasma membrane and forms a heterotetramer with annexin A2. The heterotetramer, comprising of 2 subunits of annexin A2 and S100A10, activates the plasminogen activation pathway which is involved i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358a349054367f62d9765c763f506f3d